Dr. Sarah Kerns' lab focuses on improving how prostate cancer patients are treated with radiotherapy by using advanced machine learning techniques to predict potential side effects. They aim to identify patients at risk for severe complications from treatment, which commonly affect quality of life. This research not only helps in personalizing cancer treatment but also explores the genetic factors that contribute to these adverse effects, paving the way for better patient care and therapeutic interventions.

Dr. Peter Laviolette's lab focuses on improving the diagnosis and treatment of gliomas, a type of brain tumor, by developing innovative imaging techniques. The research combines advanced mapping algorithms with MRI scans to better detect cancerous cells that are not easily visible. This work aims to refine treatment strategies and enhance patient outcomes through personalized therapy approaches and comprehensive tracking of tumor progression.

Dr. Heather A. Himburg's lab focuses on understanding how biological sex influences the body's response to radiation, specifically in gastrointestinal damage. Their research primarily investigates the role of ACE2, an enzyme that may protect against radiation injury, and how its activity differs between male and female subjects. By exploring these sex-based differences, the lab aims to develop improved medical countermeasures for radiation exposure.